Matthew R. Ruth Opiant Pharmaceuticals, Inc. (OPNT) insider trading activity

OPNT Quotes by TradingView

Matthew R. Ruth is Chief Commercial Officer of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 31,916 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $638,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Matthew R. Ruth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Sale (or disposition) back to the issuer
$638,320 $20.0 p/Share
31,916 Reduced 100.0%
0 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
2,000 Added 50.0%
2,000 Common Stock
Jul 20 2022
SELL
Open market or private sale
$11,512 $10.62 p/Share
1,084 Reduced 3.5%
29,916 Common Stock
Jun 27 2022
BUY
Grant, award, or other acquisition
-
2,000 Added 6.06%
31,000 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 29.27%
29,000 Common Stock
Aug 31 2021
BUY
Open market or private purchase
$34,680 $17.34 p/Share
2,000 Added 10.53%
17,000 Common Stock
Jul 19 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock
MRR

Matthew R. Ruth

Chief Commercial Officer
Santa Monica, CA

Track Institutional and Insider Activities on OPNT

Follow OPIANT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPNT shares.

Notify only if

Insider Trading

Get notified when an Opiant Pharmaceuticals, Inc. insider buys or sells OPNT shares.

Notify only if

News

Receive news related to OPIANT PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OPNT